Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®

Conditions: Paget's Disease of the Bone; HypocalcemiaInterventions: Drug: Reclast (ZOL446, zoledronic acid); Dietary Supplement: Calcium; Dietary Supplement: Vitamin DSponsors: Novartis; Novartis PharmaceuticalsCompleted - verified March 2014

http://clinicaltrials.gov/ct2/show/NCT00668200?lup_s=03%2F05%2F2014&lup_d=30

Source: ClinicalTrials.gov - April 22, 2008 Category: Research Source Type: clinical trials